AWAK PD Attracts Funding

Singapore-based Awak PD won FDA breakthrough device designation after completing its first-in-human study in October 2018, with no serious adverse events, and has now raised $40M in a financing round to support late-stage clinical studies and commercialization of its portable, wearable, sorbent-based PD device.

Read the full article » | Posted 01-09-2020

Related Articles

• Purchase a Report on the Wearable Dialysis Market Posted 04-19-2023
• Brief Video Discusses Implantable, Wearable, Stem Cell, and Nano Kidney Tech Posted 04-19-2023
• Fresenius wins CIO 100 Award for device to predict BP drops during HD Posted 04-19-2023
• New CAPD Device Receives FDA Approval Posted 01-10-2023